NANOXRAY
LIVE

Serial Number

79107537

Owner

NANOBIOTIX

Attorney

James R Menker

Filing Date

Nov 9, 2011

Add to watchlist:

No watchlists yet
View on USPTO

NANOXRAY Trademark

Serial Number: 79107537 • Registration: 4248033

NANOXRAY is a trademark filed by NANOBIOTIX on November 9, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NANOBIOTIX (28 trademarks)

60 rue de Wattignies

Entity Type: 99

Trademark Details

Filing Date

November 9, 2011

Registration Date

November 27, 2012

Published for Opposition

September 11, 2012

Cancellation Date

June 9, 2023

Goods & Services

Health services particularly in the field of nanomedicine, namely, use of nanomedicine in disease management programs; medical services particularly in the field of nanomedicine, namely, use of nanomedicine in disease management programs

Preparations for medical use particularly for the diagnosis and treatment of tumors; preparations for medical use particularly for the diagnosis and treatment of tumors using radiation treatment; radioactive substances for medical use for the diagnosis and treatment of tumors using radiation treatment; radiological contrast substances for medical use; chemical reagents for medical use; bacteriological preparations for medical use; enzymes for medical use; enzyme preparations for medical use; diagnostic preparations for medical use; antibiotics; antiseptics; health care preparations for treating cancer; biological preparations for medical use for the treatment of cancer; chemical preparations for medical or pharmaceutical use particularly for use in treating cancer; drugs for medical use for use in the treatment of cancer; medicines for human purposes for use in the treatment of cancer; restorative medicine for use in the treatment of oncological diseases; chemical-pharmaceutical preparations for use in treating oncological disease and disorders; pharmaceutical preparations for use in treating oncological disease and disorders

Apparatus for use in medical analysis, namely, medical X-ray apparatus, diagnostic apparatus for medical use, namely, medical X-ray apparatus; radiology screens for medical use; X-ray photographs for medical purposes; medical X-ray apparatus and installations, namely, mounts for the production of X-rays, for medical use; X-ray protection devices for medical use, namely, radiology screens; special furniture for medical use, namely, therapeutic mattresses, beds, seats and cushions

Scientific and technological services, namely, research and design services in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications for use in nanomedicine which is nanotechnology applied to medicine; scientific and technological evaluations, estimates and investigations provided by engineers, researchers in the field of nanomedicine; technical project studies, namely, technical research in the field of nanomedicine; industrial analysis and research services in the field of nanomedicine; chemistry services, namely, chemistry consultation; expert appraisals in the field of engineering, namely, consultation in the field of engineering; technical research in the field of nanomedicine

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 3, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 9, 2024 INTS
INVALIDATION PROCESSED
Feb 9, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 9, 2024 INTR
CANCELLED SECTION 71
Jun 9, 2023 C71T
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 27, 2021 REM4
INTERNATIONAL REGISTRATION RENEWED
Nov 26, 2021 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 17, 2019 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 17, 2019 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jul 4, 2019 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Jan 17, 2019 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 17, 2019 APRE
TEAS SECTION 71 RECEIVED
Nov 27, 2018 ES71
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 6, 2013 FICS
FINAL DISPOSITION PROCESSED
Mar 6, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 27, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 27, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Oct 16, 2012 GPNX
PUBLISHED FOR OPPOSITION
Sep 11, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 22, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 22, 2012 OP2R
NOTICE OF PUBLICATION
Aug 22, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 9, 2012 PREV
ASSIGNED TO LIE
Aug 9, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2012 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2012 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2012 TROA
REFUSAL PROCESSED BY IB
Mar 27, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 5, 2012 RFCS
REFUSAL PROCESSED BY MPU
Mar 5, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 2, 2012 RFCR
NON-FINAL ACTION WRITTEN
Mar 1, 2012 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 1, 2012 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2012 RFCR
NON-FINAL ACTION WRITTEN
Feb 29, 2012 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2012 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 17, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2012 REPR